THESEUS PHARMACEUTICALS INC shareholders Q3 2023

THESEUS PHARMACEUTICALS INC's ticker is and the CUSIP is 88369M101. A total of 64 filers reported holding THESEUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.

THESEUS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Walleye Capital LLC 31,998$86,0750.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11,112$29,8910.00%
Tower Research Capital LLC (TRC) 5,734$15,4240.00%
JPMORGAN CHASE & CO 13,141$35,3490.00%
BARCLAYS PLC 7,832$210.00%
ROYAL BANK OF CANADA 6,756$18,0000.00%
VANGUARD GROUP INC 789,120$2,122,7320.00%
Ameritas Investment Partners, Inc. 889$2,3910.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 4,466$12,0140.00%
UBS Group AG 10,750$28,9180.00%
ALLIANCEBERNSTEIN L.P. 15,620$42,0180.00%
RHUMBLINE ADVISERS 27,958$75,1980.00%
PRINCIPAL FINANCIAL GROUP INC 10,679$28,7260.00%
Glassman Wealth Services 241$6480.00%
Squarepoint Ops LLC 19,653$52,8670.00%
TWO SIGMA INVESTMENTS, LP 22,651$60,9310.00%
OSAIC HOLDINGS, INC. 2,793$7,5130.00%
FMR LLC 755$2,0310.00%
DIMENSIONAL FUND ADVISORS LP 46,153$124,1520.00%
AMERICAN INTERNATIONAL GROUP, INC. 10,100$27,1690.00%

This page lists THESEUS PHARMACEUTICALS INC's shareholders in Q3 2023. To view THESEUS PHARMACEUTICALS INC's shareholder history, click here.